TEVA PHARMACEUTICAL FINANCE NETHERLANDS III B.V., as Issuer TEVA PHARMACEUTICAL INDUSTRIES LIMITED, as Guarantor and THE BANK OF NEW YORK MELLON, as Trustee FIRST SUPPLEMENTAL SENIOR INDENTURE Dated as of July 21, 2016 to the Senior Indenture dated as...First Supplemental Senior Indenture • July 21st, 2016 • Teva Pharmaceutical Industries LTD • Pharmaceutical preparations • New York
FIRST SUPPLEMENTAL SENIOR INDENTURE, dated as of July 21, 2016, among Teva Pharmaceutical Finance Netherlands III B.V., a private company with limited liability (besloten vennootschap met beperkte aansprakelijkheid), incorporated under Dutch law (the “Issuer”), Teva Pharmaceutical Industries Limited, a corporation incorporated under the laws of Israel (the “Guarantor”), and The Bank of New York Mellon, a New York banking corporation, as trustee (the “Trustee”),
as IssuerFirst Supplemental Senior Indenture • January 27th, 2004 • Teva Pharmaceutical Industries LTD • Pharmaceutical preparations • New York
TEVA PHARMACEUTICAL FINANCE NETHERLANDS III B.V., as Issuer, TEVA PHARMACEUTICAL INDUSTRIES LIMITED, as Guarantor, and THE BANK OF NEW YORK MELLON, as Trustee FIRST SUPPLEMENTAL SENIOR INDENTURE Dated as of March 14, 2018 to the Senior Indenture dated...First Supplemental Senior Indenture • March 14th, 2018 • Teva Pharmaceutical Industries LTD • Pharmaceutical preparations • New York
FIRST SUPPLEMENTAL SENIOR INDENTURE, dated as of March 14, 2018, by and among Teva Pharmaceutical Finance Netherlands III B.V., a private company with limited liability (besloten vennootschap met beperkte aansprakelijkheid), incorporated under Dutch law (the “Issuer”), Teva Pharmaceutical Industries Limited, a corporation incorporated under the laws of Israel (the “Guarantor”), and The Bank of New York Mellon, a New York banking corporation, as trustee (the “Trustee”).
TEVA PHARMACEUTICAL FINANCE COMPANY B.V., as Issuer TEVA PHARMACEUTICAL INDUSTRIES LIMITED, as Guarantor and THE BANK OF NEW YORK, as TrusteeFirst Supplemental Senior Indenture • January 31st, 2006 • Teva Pharmaceutical Industries LTD • Pharmaceutical preparations • New York
FIRST SUPPLEMENTAL INDENTURE, dated as of January 31, 2006, among Teva Pharmaceutical Finance Company B.V., a private limited liability company formed under the laws of the Netherlands Antilles (the “Issuer”), Teva Pharmaceutical Industries Limited, a corporation incorporated under the laws of Israel (the “Guarantor”), and The Bank of New York, as trustee (the “Trustee”),
AMARIN CORPORATION PLC, as Issuer and WILMINGTON TRUST COMPANY, as Trustee FIRST SUPPLEMENTAL SENIOR INDENTURE Dated as of December 6, 2007 to the Senior Indenture dated as of December 6, 2007 Creating the series of debentures designated 8%...First Supplemental Senior Indenture • December 17th, 2007 • Amarin Corp Plc\uk • Pharmaceutical preparations • New York
FIRST SUPPLEMENTAL INDENTURE, dated as of December 6, 2007, between Amarin Corporation plc, a public limited company registered in England and Wales (the “Issuer”), and Wilmington Trust Company, as trustee (the “Trustee”).
SUPPLEMENTAL TO AMENDED AND RESTATED SENIOR INDENTURE DATED MAY 1, 1999First Supplemental Senior Indenture • January 19th, 2001 • Morgan Stanley Dean Witter & Co • Finance services • New York
